Honduras vs Myanmar: Share of the population living with HIV receiving antiretroviral therapy
Honduras
74.2%
in 2024
Myanmar
74.7%
in 2024
Honduras rank
68th
Myanmar rank
65th
Share of the population living with HIV receiving antiretroviral therapy over time
- Honduras
- Myanmar
How they compare
Myanmar currently reports 74.7% against 74.2% in Honduras, a difference of 0.5%.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Myanmar ahead.
Honduras ranks 68th and Myanmar ranks 65th of 149 countries.
Across the 4 decades both report, Honduras averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Honduras | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 12.3% | 2.4% | 9.9% | Honduras |
| 2010s | 49.2% | 37.6% | 11.6% | Honduras |
| 2020s | 68.8% | 72.9% | 4.0% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Honduras or Myanmar?
- Myanmar, at 74.7% against 74.2% in Honduras as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Honduras and Myanmar?
- 0.5%, with Myanmar ahead.
- How many years of comparable data are there for Honduras and Myanmar?
- 35 years are reported by both, from 1990 to 2024.
- How do Honduras and Myanmar rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Honduras ranks 68th and Myanmar ranks 65th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.